The V3 loop based multi-epitope polypeptide TAB9 adjuvated with montanide ISA720 is highly immunogenic in nonhuman primates and induces neutralizing antibodies against five HIV-1 isolates

Vaccine. 1999 May 4;17(18):2311-9. doi: 10.1016/s0264-410x(98)00358-2.

Abstract

In a previous work we selected montanide ISA720 (M-ISA720) among different adjuvants for the vaccination with a V3 loop based multi-epitope polypeptide TAB9. In this paper we present the evaluation of the toxicity and immunogenicity of this formulation in non-human primates. TAB9 in M-ISA720 was highly immunogenic in macaques (Macaca fascicularis) inducing antibodies against TAB9 in all animals after one inoculation and a strong anamnestic response after booster injections. Furthermore 97% of the V3 peptides included were recognized by TAB9 sera. No differences between doses of 200 microg and 1 mg of TAB9 in M-ISA720 were observed after four immunizations. Neutralizing antibodies against five HIV-1 isolates were detected in most animals. Animals remain healthy throughout the study and did not show lesions at the inoculation site.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Amino Acid Sequence
  • Animals
  • Antibodies, Viral / biosynthesis*
  • Antibody Affinity
  • Consensus Sequence
  • Enzyme-Linked Immunosorbent Assay
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Immunodominant Epitopes / immunology*
  • Macaca radiata
  • Mannitol / analogs & derivatives*
  • Mannitol / immunology
  • Molecular Sequence Data
  • Neutralization Tests
  • Oils
  • Oleic Acids / immunology*
  • Peptides / immunology*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Viral
  • Immunodominant Epitopes
  • Oils
  • Oleic Acids
  • Peptides
  • mannide monooleate
  • Mannitol